The Burden of Hiv in Iran: Insights From the Global Burden of Disease Study 2010 Pubmed



Noori A^{1, 2} ; Rahimzadeh S^{1, 3} ; Moradi G⁴ ; Saeedi Moghaddam S^{1, 5} ; Naderimagham S^{1, 2} ; Shalmani HM^{1, 6} ; Kompani F⁷ ; Rezaei N^{1, 2} ; Shokoohi M^{1, 8}
Source: Archives of Iranian Medicine Published:2016

Abstract

OBJECTIVES: To evaluate the HIV/AIDS burden in Iran from 1980 to 2010 using the Global Burden of Disease Study 2010 (GBD 2010). METHODS: The burden of HIV/AIDS in Iran was obtained from a systematic study from 1990 to 2010 by the GBD team. The GBD 2010 disability weights were used to calculate the HIV/AIDS Disability Adjusted Life Years (DALY) based on the HIV prevalence reported by the Joint United Nations Program on HIV/AIDS (UNAIDS) estimation. Mortality data were obtained from the vital registration and statistics system of Iran. In the current study, the results are discussed, and the potential solutions are provided for observed deficiencies. RESULTS: HIV/AIDS-related DALYs (3.6 per 100,000 in 1990, and 154 per 100,000 in 2010) and death (0.07 per 100,000 in 1990, and 3 per 100,000 in 2010) had increased in Iran from 1990 to 2010. The majority of individuals who died of HIV were between 15 to 49 years old. The estimated rank of HIV/AIDS burden compared with the burden of other leading disease was 152nd in 1990 and considerably increased to 37th in 2010 in Iran. CONCLUSION: Since the majority of HIV/AIDS DALYs and deaths occur among young people, the burden of HIV/AIDS still remains high in Iran. Due to the limitations of the GBD study, National and Sub-National Burden of Diseases (NASBOD) study is being conducted in Iran to calculate the burden of diseases, including HIV/AIDS. © 2016, Academy of Medical Sciences of I.R. Iran. All rights reserved.